Regeneron’s CEO Says We Could Have a Covid-19 Treatment ‘Quickly’

Regeneron Pharmaceuticals announced a breakthrough in the search for a Covid-19 treatment. It has identified hundreds of virus-neutralizing antibodies that could potentially be used in a cocktail drug.

“Similar to the approach the company pursued for Mers and Ebola virus, we believe Regeneron’s Covid-19 antibody cocktail may offer efficacy in preventing and treating the virus,” SVB Leerink analyst Geoffrey Porges wrote in a note to investors.

Visit the article here.